NCT06060483View on ClinicalTrials.gov

Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis

NANot yet recruitingINTERVENTIONAL

Enrollment

4,000

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Diabetes Mellitus, Type 2Major Adverse Cardiac Events

Interventions

DEVICE

CGM

Wear CGM continuously and manage patients based on CGM. The treatment goals are TIR\>70%, TBR\<4%, TAR\<25%, and HbA1c\<7.0%. After the treatment reaches the standard, CGM is worn every six months.

Trial Locations (1)

310009

the Second Affiliated Hospital Zhejiang University Schoolof Medicine, Hangzhou

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER